A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen
Abstract Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To improve the treatment outcome in DR-TB, therapeutic vaccines are considered an ideal choice as they can enhance pathogen clearance and minimize di...
Saved in:
Published in | bioRxiv |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Paper |
Language | English |
Published |
Cold Spring Harbor
Cold Spring Harbor Laboratory Press
05.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To improve the treatment outcome in DR-TB, therapeutic vaccines are considered an ideal choice as they can enhance pathogen clearance and minimize disease sequelae. To date, there is no therapeutic vaccine reported to be effective when combined with a chemotherapy regimen against DR-TB. The only available TB vaccine, the M. bovis BCG (BCG) is susceptible to several anti-TB drugs hence not a perfect option for therapeutic vaccination. Herein, we developed a recombinant BCG (RdrBCG) overexpressing Ag85B and Rv2628 with resistance to selected anti-TB drugs. When administered three times adjunct to a second-line anti-TB regimen in a classical murine model of DR-TB, the RdrBCG lowered lung M. tuberculosis colony-forming units by 1 log10. Furthermore, vaccination with the RdrBCG adjunct to TB chemotherapy minimized lung tissue pathology in mice. Most importantly, the RdrBCG maintained the exogenously inserted genes and showed almost the same virulence as its parent BCG Tice strain in severe combined immune-deficient mice. All these suggested that the RdrBCG was stable, safe and effective. Hence, the “recombinant” plus “drug-resistant” BCG strategy could be a useful concept for developing therapeutic vaccines against DR-TB. |
---|---|
AbstractList | Abstract Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To improve the treatment outcome in DR-TB, therapeutic vaccines are considered an ideal choice as they can enhance pathogen clearance and minimize disease sequelae. To date, there is no therapeutic vaccine reported to be effective when combined with a chemotherapy regimen against DR-TB. The only available TB vaccine, the M. bovis BCG (BCG) is susceptible to several anti-TB drugs hence not a perfect option for therapeutic vaccination. Herein, we developed a recombinant BCG (RdrBCG) overexpressing Ag85B and Rv2628 with resistance to selected anti-TB drugs. When administered three times adjunct to a second-line anti-TB regimen in a classical murine model of DR-TB, the RdrBCG lowered lung M. tuberculosis colony-forming units by 1 log10. Furthermore, vaccination with the RdrBCG adjunct to TB chemotherapy minimized lung tissue pathology in mice. Most importantly, the RdrBCG maintained the exogenously inserted genes and showed almost the same virulence as its parent BCG Tice strain in severe combined immune-deficient mice. All these suggested that the RdrBCG was stable, safe and effective. Hence, the “recombinant” plus “drug-resistant” BCG strategy could be a useful concept for developing therapeutic vaccines against DR-TB. |
Author | Guan, Ping Tan, Shouyong Mugweru, Julius N Gift Chiwala Shahzad Akbar Khan Buhari Yusuf Zhong, Nanshan Petuel Ndip Ndip Bate Hm Adnan Hameed Liu, Zhiyong Hu, Jinxing Wang, Bangxing Tan, Yaoju Liu, Jianxiong Zhang, Tianyu Fang, Cuiting |
Author_xml | – sequence: 1 fullname: Gift Chiwala – sequence: 2 givenname: Zhiyong surname: Liu fullname: Liu, Zhiyong – sequence: 3 givenname: Julius surname: Mugweru middlename: N fullname: Mugweru, Julius N – sequence: 4 givenname: Bangxing surname: Wang fullname: Wang, Bangxing – sequence: 5 fullname: Shahzad Akbar Khan – sequence: 6 fullname: Petuel Ndip Ndip Bate – sequence: 7 fullname: Buhari Yusuf – sequence: 8 fullname: Hm Adnan Hameed – sequence: 9 givenname: Cuiting surname: Fang fullname: Fang, Cuiting – sequence: 10 givenname: Yaoju surname: Tan fullname: Tan, Yaoju – sequence: 11 givenname: Ping surname: Guan fullname: Guan, Ping – sequence: 12 givenname: Jinxing surname: Hu fullname: Hu, Jinxing – sequence: 13 givenname: Shouyong surname: Tan fullname: Tan, Shouyong – sequence: 14 givenname: Jianxiong surname: Liu fullname: Liu, Jianxiong – sequence: 15 givenname: Nanshan surname: Zhong fullname: Zhong, Nanshan – sequence: 16 givenname: Tianyu surname: Zhang fullname: Zhang, Tianyu |
BookMark | eNotkD1PwzAURT3AAIUfwGaJOcHPHyQZSwQFqYile2U7L61RahfbqYTEj8cVTHe4uudI95pc-OCRkDtgNQCDB8441EzUTNZSSMblFflZ0og2HIzz2meacEKb3QnpEOddFTG5lM_Fe01NOLlEn_oVRb_X3mKieY_UaJsxOusGPVF9Hrv8TcNIdaHZ4Idqch5png1GO0-hEIty5w7ob8jlqKeEt_-5IJuX503_Wq0_Vm_9cl0dG5CVBIlaAOOjNMp2IM0AehibznApxNjhIFWrTMMUGNY0pjWgZAvw2LVS8BHEgtz_YY8xfM2Y8vYzzNEX45arslJQvhC_jURbDA |
ContentType | Paper |
Copyright | 2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.03.04.434024v1 |
Copyright_xml | – notice: 2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.03.04.434024v1 |
DBID | 8FE 8FH AAFGM AAMXL ABOIG ABUWG ADZZV AFKRA AFLLJ AFOLM AGAJT AQTIP AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PIMPY PQCXX PQEST PQQKQ PQUKI PRINS |
DOI | 10.1101/2021.03.04.434024 |
DatabaseName | ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central Korea - hybrid linking Natural Science Collection - hybrid linking Biological Science Collection - hybrid linking ProQuest Central (Alumni Edition) ProQuest Central (Alumni) - hybrid linking ProQuest Central SciTech Premium Collection - hybrid linking ProQuest Central Student - hybrid linking ProQuest Central Essentials - hybrid linking ProQuest Women's & Gender Studies - hybrid linking ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database Publicly Available Content Database ProQuest Central - hybrid linking ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | Publicly Available Content Database ProQuest Central Student ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest One Academic |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Genre | Working Paper/Pre-Print |
GroupedDBID | 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PIMPY PQEST PQQKQ PQUKI PRINS |
ID | FETCH-LOGICAL-p714-414ea3102f4b5c914bd1adf79b2433f9ed4585b7051b077b8b154811698432f13 |
IEDL.DBID | BENPR |
IngestDate | Fri Sep 13 03:16:40 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p714-414ea3102f4b5c914bd1adf79b2433f9ed4585b7051b077b8b154811698432f13 |
OpenAccessLink | https://www.proquest.com/docview/2505151402/abstract/?pq-origsite=%requestingapplication% |
PQID | 2505151402 |
PQPubID | 2050091 |
ParticipantIDs | proquest_journals_2505151402 |
PublicationCentury | 2000 |
PublicationDate | 20210305 |
PublicationDateYYYYMMDD | 2021-03-05 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210305 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | Cold Spring Harbor |
PublicationPlace_xml | – name: Cold Spring Harbor |
PublicationTitle | bioRxiv |
PublicationYear | 2021 |
Publisher | Cold Spring Harbor Laboratory Press |
Publisher_xml | – name: Cold Spring Harbor Laboratory Press |
Score | 1.6546152 |
Snippet | Abstract Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To... |
SourceID | proquest |
SourceType | Aggregation Database |
SubjectTerms | Animal models Bactericidal activity Chemotherapy Combined vaccines Complications Drug resistance Immune clearance Immunization Immunosuppressive agents Isoniazid Rifampin Tuberculosis Vaccines Virulence |
Title | A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen |
URI | https://www.proquest.com/docview/2505151402/abstract/ |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NSwNBDB1qe_GmqPhRZQ5ex3Z2szvdk6i0FkERqeBNJjNZLbS7tdt68sc7Wbd4EDwHckiGJC_J5AlxHhuyRpNTNotSBTRIFPYdKGOtSYlyjDz3O-4f0vEz3L0kLy0x3vyF4bXKTUysA7UvHffIe5yqQ3YKcKdnkbsAbtW7XHwo5o_iOWtDprElOpEGHth2rocPj0_NIDM8PIb5uj5oChcQBz3wJ_zWOWW0IzqPdkHLXdGiYk98XUnGpnOsN1NkVdPThEgk_XL9pgIm5jovCO4vJJaf00pe39xKKt7ZaZUMVZzEn7vLburtTPJ3BWaFkGUubdAWUK9XXFHK1Rpp6dazMmiUTMswp2JfTEbDyc1YNcwIamE0KNBANtRlUQ6YuEwDem19bjKMII7zjDwEFIAmWAz7xuAAGZhonWYDiKNcxweiXZQFHQqZR5oSsP3MegOEFl0KiWEqstiRT_Mj0d3Y6LV53dXrry-O_xefiG22er2zlXRFe7Vc02lI4is8a_zzDTHxoHM |
link.rule.ids | 786,790,21416,27958,33779,43840 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTwIxEG0UDnrTqPEDtQevRbo7u2VPRgiICoQYTLiRdjurJrDgLnvzxztdl3gw8dy0h5lm5r2ZaR9jN75CrSTGQkdeKADbgTCtGITSWoWIifGsq3eMxuHgFZ5mwawquOXVWOU2JpaB2q5iVyO_damashPRnbv1p3CqUa67Wklo7LI6-ERVaqze6Y0nL1X7kq6bI_ey_MYUmuDTbvgTdMtM0j9g9YleY3bIdjA9Yl_33DHSpSnnUXheitJQ_OE2K94EMWGH7mhh1OSGqH_OO90Hjum7c1XOCbtx8_Pbcvxh9YK7RwpOC4KvEq7pNOK6VjgcyTeFwSwuFis6kTsxhiWmx2za7027A1HpIYi1kiBAAmpCY14CJogjCcZKbRMVGQ98P4nQAmF_o8hOpqWUaRtHR6QMozb4XiL9E1ZLVymeMp54EgPQrUhbBWi0iUMIlBMg82O0YXLGGlsbzas7nc9_PXD-__I12xtMR8P58HH8fMH2nQfKqa2gwWqbrMBLSuMbc1X56hvxQp-m |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+recombinant+selective+drug-resistant+M.+bovis+BCG+enhances+the+bactericidal+activity+of+a+second-line+tuberculosis+regimen&rft.jtitle=bioRxiv&rft.au=Gift+Chiwala&rft.au=Liu%2C+Zhiyong&rft.au=Mugweru%2C+Julius+N&rft.au=Wang%2C+Bangxing&rft.date=2021-03-05&rft.pub=Cold+Spring+Harbor+Laboratory+Press&rft_id=info:doi/10.1101%2F2021.03.04.434024 |